These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 18638373)

  • 1. Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.
    Rodenhiser DI; Andrews J; Kennette W; Sadikovic B; Mendlowitz A; Tuck AB; Chambers AF
    Breast Cancer Res; 2008; 10(4):R62. PubMed ID: 18638373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-platform whole-genome microarray analyses refine the epigenetic signature of breast cancer metastasis with gene expression and copy number.
    Andrews J; Kennette W; Pilon J; Hodgson A; Tuck AB; Chambers AF; Rodenhiser DI
    PLoS One; 2010 Jan; 5(1):e8665. PubMed ID: 20084286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of epigenetically regulated genes in breast cancer cell lines.
    Loss LA; Sadanandam A; Durinck S; Nautiyal S; Flaucher D; Carlton VE; Moorhead M; Lu Y; Gray JW; Faham M; Spellman P; Parvin B
    BMC Bioinformatics; 2010 Jun; 11():305. PubMed ID: 20525369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.
    Li Y; Li S; Chen J; Shao T; Jiang C; Wang Y; Chen H; Xu J; Li X
    Hum Mol Genet; 2014 Oct; 23(20):5378-93. PubMed ID: 24871326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
    Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
    Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of epigenetic alterations using tiling arrays.
    Cheung HH; Rennert OM; Lee TL
    Methods Mol Biol; 2013; 1067():79-86. PubMed ID: 23975787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ITIH5 mediates epigenetic reprogramming of breast cancer cells.
    Rose M; Kloten V; Noetzel E; Gola L; Ehling J; Heide T; Meurer SK; Gaiko-Shcherbak A; Sechi AS; Huth S; Weiskirchen R; Klaas O; Antonopoulos W; Lin Q; Wagner W; Veeck J; Gremse F; Steitz J; Knüchel R; Dahl E
    Mol Cancer; 2017 Feb; 16(1):44. PubMed ID: 28231808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer.
    Ramos EA; Grochoski M; Braun-Prado K; Seniski GG; Cavalli IJ; Ribeiro EM; Camargo AA; Costa FF; Klassen G
    PLoS One; 2011; 6(12):e29461. PubMed ID: 22220212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage-specific methylome screen identifies that NEFL is downregulated by promoter hypermethylation in breast cancer.
    Kang S; Kim B; Park SB; Jeong G; Kang HS; Liu R; Kim SJ
    Int J Oncol; 2013 Nov; 43(5):1659-65. PubMed ID: 24026393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modulation of BRCA-1 and MGMT genes, and histones H4 and H3 are associated with breast tumors.
    Paydar P; Asadikaram G; Nejad HZ; Akbari H; Abolhassani M; Moazed V; Nematollahi MH; Ebrahimi G; Fallah H
    J Cell Biochem; 2019 Aug; 120(8):13726-13736. PubMed ID: 30938887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.
    Rauscher GH; Kresovich JK; Poulin M; Yan L; Macias V; Mahmoud AM; Al-Alem U; Kajdacsy-Balla A; Wiley EL; Tonetti D; Ehrlich M
    BMC Cancer; 2015 Oct; 15():816. PubMed ID: 26510686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes.
    Messier TL; Gordon JA; Boyd JR; Tye CE; Browne G; Stein JL; Lian JB; Stein GS
    Oncotarget; 2016 Feb; 7(5):5094-109. PubMed ID: 26783963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modifications, chromatin distribution and TP53 transcription in a model of breast cancer progression.
    Santos GC; da Silva AP; Feldman L; Ventura GM; Vassetzky Y; de Moura Gallo CV
    J Cell Biochem; 2015 Apr; 116(4):533-41. PubMed ID: 25358520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic variations in breast cancer progression to lymph node metastasis.
    Urrutia G; Laurito S; Marzese DM; Gago F; Orozco J; Tello O; Branham T; Campoy EM; Roqué M
    Clin Exp Metastasis; 2015 Feb; 32(2):99-110. PubMed ID: 25628026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells.
    Sadikovic B; Andrews J; Carter D; Robinson J; Rodenhiser DI
    J Biol Chem; 2008 Feb; 283(7):4051-60. PubMed ID: 18065415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
    Roll JD; Rivenbark AG; Jones WD; Coleman WB
    Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation-dependent silencing of CST6 in primary human breast tumors and metastatic lesions.
    Rivenbark AG; Livasy CA; Boyd CE; Keppler D; Coleman WB
    Exp Mol Pathol; 2007 Oct; 83(2):188-97. PubMed ID: 17540367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins.
    Tryndyak VP; Kovalchuk O; Pogribny IP
    Cancer Biol Ther; 2006 Jan; 5(1):65-70. PubMed ID: 16322686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
    Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.